Leading the Way in Discovering Novel Treatments for Pancreatic Cancer
Commitment to Research
The LaBahn Pancreatic Cancer Program supports internationally recognized specialists who provide a wealth of knowledge and experience in pancreatic cancer treatment and research. We are committed to developing the next generation of medical researchers and to translating our research into cutting-edge treatments for our patients. We are involved in many areas of research, including basic science, outcomes assessments, and international clinical trials. Our dedication to research is one of the many tools we have available to make 老澳门六合彩图库 a destination for the best pancreatic cancer care possible.
About our Biorepository
Our biorepository is a phenomenal resource for both translational research collaborations as well as clinical outcomes research. The Ronald Burklund Eich integrated biorepository and database captures longitudinal samples from patients across a broad spectrum of disease, from pancreatic cancer screening to diagnosis, and even post-mortem.
Basic and Translational Scientific Investigators
Scientific investigators are discovery-drivers, working to uncover more innovative and cutting-edge treatments with every study they conduct.
Michael B. Dwinell, PhD
Professor; Founding Director, Center for Immunology; Director, Bobbie Nick Voss Laboratory for Colon Cancer Research; Hanis-Stepka-Rettig Endowed Chair in Cancer Research
Cancer Metastasis, Tumor Microenvironment, Mucosal Inflammation
Guan Chen, MD, PhD
Professor
Gwen Lomberk, PhD
Chief, Division of Research; Director, Basic Science Research; Department of Surgery; Professor of Surgery and Pharmacology & Toxicology
Nikki K. Lytle, PhD
Assistant Professor
Subramaniam Malarkannan, PhD
Professor and Gardetto Chair for Immunology and Immunotherapy; Professor, Medicine (Hematology and Oncology) and Microbiology & Immunology; Senior Investigator, Versiti Blood Research Institute
NK cell development and function
Thomas McFall, PhD
Assistant Professor
I am interested in experimental-systems approaches that enable mechanism-based inference in genomic medicine and can help identify patients for selective therapeutic strategies.
Jong-In Park, PhD
Professor; Eminent Scholar
Raul A. Urrutia, MD
Professor, Department of Surgery; Director, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine
Research Lab Links and More
-
Department of Surgery- Division of Research
Learn More -
Dr. Dwinell's Lab Page
Learn More -
Dr. Lomberk's Lab Page
Learn More -
Dr. Park's Lab Page
Learn More -
Dr. Urrutia's Lab Page
Learn More
Recent Publications
-
(Dong J, Arsang-Jang S, Zhang T, Chen Z, Bolon YT, Spellman S, Urrutia R, Auer P, Saber W.) J Hematol Oncol. 2024 Nov 04;17(1):104 PMID: 39497145 PMCID: PMC11533675 SCOPUS ID: 2-s2.0-85208516411 11/05/2024
-
(Vallmajo-Martin Q, Ma Z, Srinivasan S, Murali D, Dravis C, Mukund K, Subramaniam S, Wahl GM, Lytle NK.) bioRxiv. 2024 Nov 04 PMID: 39415993 PMCID: PMC11482796 10/17/2024
-
(Becker AE, Kochanowski P, Wu PK, W膮tor E, Chen W, Guchhait K, Biela AP, Grudnik P, Park JI.) Cell Rep. 2024 Oct 22;43(10):114831 PMID: 39392755 PMCID: PMC11544350 SCOPUS ID: 2-s2.0-85207351264 10/11/2024
-
(Drouillard D, Halyko M, Cinquegrani E, McAllister D, Peterson FC, Marchese A, Dwinell MB.) bioRxiv. 2024 Aug 27 PMID: 39253415 PMCID: PMC11383031 09/10/2024
-
(Seo YD, Pollack SM.) JAMA Oncol. 2024 Jun 01;10(6):830-831 PMID: 38602667 SCOPUS ID: 2-s2.0-85190480277 04/11/2024
-
(Pollin G, Lomberk GA, Mathison AJ, Zimmermann MT, Urrutia R.) Journal of Gastrointestinal Oncology. 31 August 2024;15(4):1996-2001 SCOPUS ID: 2-s2.0-85203321495 08/31/2024
-
(McFall T, Stites EC.) Cell Rep. 2021 Dec 14;37(11):110096 PMID: 34910921 PMCID: PMC8867612 SCOPUS ID: 2-s2.0-85121146579 12/16/2021